Back to R2 link
Top Industry News
- MHRA - Marketing Authorisation Holders Submission of Nitrosamine Risk Evaluation, Risk Assessment and Confirmatory Testing
- EU Regulation Includes Vit A in List of 9 Cosmetic Ingredients: Impact on Cosmetic Products Market
- TGA Updates to the Sunscreen Standard
- MHRA Guidance on Rolling Review for Marketing Authorisation Applications
- FDA Guidance Document on Data Standards Catalog
- MHRA Guidance on The 150-day Assessment for National Applications for Medicines
- Medical Devices Given Exceptional Use Authorisations During the COVID-19 Pandemic
- UK Product Safety Database Alerts January, February and March 2024
- PMDA Guidelines for Promoting Optimal Use of Pharmaceuticals
- FDA Issues Report Regarding Economically Driven Adulteration in Honey
- FSSAI Cracks Down on Mislabelling: Dairy and Cereal-Based Drinks Misidentified as Health and Energy Drinks Online
- SCCS Provides Opinion on Triphenyl Phosphate (CAS No. 204-112-2, EC No. 115-86-6)
- MHRA Performance Data for Assessment of Clinical Trials and Established Medicines
- CDRH Unveils New Dataset to Help Improve Chemical Characterization Methods for Biocompatibility of Medical Devices